Corporate action, page-68

I ageee with your sentiments and I'm top 20.
The next 3 months are pivotal to PAA start of success that can be validated and recognised by the market, especially if the phase 2/3 can commence with FDA ODD, trial acceleration and possible grant funds.
Through this period we need strong, experienced, knowledgeable executive leadership, that know how to make the most of the opportunity that now faces us as shareholders. SP should already be 50c or more at this stage, and look where it's at, mainly due to lack of communication! MT is good for the company.